Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AKTS | Aktis Oncology, Inc. | Healthcare | 4,835,872.0 | $86.5M | 6.68% | NEW | — | $17.89 | +6.9% |
| 2 | CORT | Corcept Therapeutics, Inc. | Healthcare | 985,700.0 | $39.7M | 3.07% | NEW | — | $40.31 | +48.1% |
| 3 | DNTH | Dianthus Therapeutics Inc | Healthcare | 423,982.0 | $35.6M | 2.75% | NEW | — | $83.92 | +6.8% |
| 4 | MLTX | MoonLake Immunotherapeutics | Healthcare | 1,811,082.0 | $33.8M | 2.61% | NEW | — | $18.64 | -0.9% |
| 5 | TVTX | Travere Therapeutics Inc | Healthcare | 1,133,365.0 | $33.7M | 2.60% | NEW | — | $29.71 | +46.4% |
| 6 | CYTK | Cytokinetics Inc | Healthcare | 500,000.0 | $33.0M | 2.54% | NEW | — | $65.91 | +18.4% |
| 7 | — | Forte Biosciences, Inc. | — | 1,000,682.0 | $25.9M | 2.00% | NEW | — | $25.90 | — |
| 8 | — | Zymeworks, Inc. | — | 565,249.0 | $14.2M | 1.09% | NEW | — | $25.04 | — |
| 9 | VRDN | Viridian Therapeutics Inc | Healthcare | 649,873.0 | $12.7M | 0.98% | NEW | — | $19.56 | -9.9% |
| 10 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 2,242,933.0 | $5.5M | 0.42% | NEW | — | $2.44 | -19.7% |
| 11 | ACRS | Aclaris Therapeutics Inc | Healthcare | 391,918.0 | $1.5M | 0.11% | NEW | — | $3.75 | +21.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%